A Growing Backlog Of Biotechs Haven’t Raised Funding Since The Boom As biotech startup funding continues to decline, the backlog of funded, private companies that haven’t raised capital in several years has grown quite large.
Per Crunchbase data, more than 200 private U.S. biotechs with $50 million or more in fundin... Read More